Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only

Home/GA/Augusta

Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Augusta, GA

Studies commonly pay $75 to $4,500 per completed study

184 clinical trials are currently recruiting participants within 30 miles of Augusta. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

184studies recruiting

5+research centers nearby

6condition categories

Live from the NIH registry

Studies recruiting near Augusta right now

Top 25 of 184 recruiting studies, sorted by proximity — each links to its official registry page

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought

Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT04251052)

Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)

Hereditary Hemorrhagic Telangiectasia (HHT), Osler Weber Rendu Disease Phase 1, Phase 2 Interventional 100 participants sought

Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: Atavistik Bio, Inc

See eligibility & contact on ClinicalTrials.gov (NCT07601425)

Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure

Multiple Myeloma, Renal Failure EARLY/Phase 1 Interventional 30 participants sought

Georgia Cancer Center-Augusta University — Augusta, Georgia (9.2 mi) · Sponsor: Augusta University

See eligibility & contact on ClinicalTrials.gov (NCT06142396)

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Solid Tumor, Advanced Solid Tumor Phase 1 Interventional 238 participants sought

Augusta University — Augusta, Georgia (9.2 mi) · Sponsor: NiKang Therapeutics, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06586957)

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Schizophrenia, Schizoaffective Disorder Phase 4 Interventional 100 participants sought

Neurocrine Clinical Site — Augusta, Georgia (9.2 mi) · Sponsor: Neurocrine Biosciences

See eligibility & contact on ClinicalTrials.gov (NCT07105111)

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

Focal Segmental Glomerulosclerosis Phase 2 Interventional 60 participants sought

Investigator Site #29 — Augusta, Georgia (9.2 mi) · Sponsor: Akebia Therapeutics

See eligibility & contact on ClinicalTrials.gov (NCT07268638)

Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema

Diabetic Retinopathy Phase 2, Phase 3 Interventional 576 participants sought

Southeast Retina Center /ID# 274739 — Augusta, Georgia (9.2 mi) · Sponsor: AbbVie

See eligibility & contact on ClinicalTrials.gov (NCT07592273)

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.

Candidemia, Candidiasis, Invasive Phase 3 Interventional 450 participants sought

Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: Basilea Pharmaceutica

See eligibility & contact on ClinicalTrials.gov (NCT05421858)

Galleri® in the Medicare Population.

Cancer N/A Interventional 50,000 participants sought

HCA Healthcare Doctors Hospital — Augusta, Georgia (9.2 mi) · Sponsor: GRAIL, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT05673018)

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

Cervical Cancer Phase 4 Interventional 100 participants sought

Georgia Cancer Center at Augusta University — Augusta, Georgia (9.2 mi) · Sponsor: Pfizer

See eligibility & contact on ClinicalTrials.gov (NCT06952660)

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

Neuroblastoma Phase 2 Interventional 500 participants sought

Augusta University Health — Augusta, Georgia (9.2 mi) · Sponsor: Giselle Sholler

See eligibility & contact on ClinicalTrials.gov (NCT02559778)

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8 Phase 3 Interventional 474 participants sought

Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05624996)

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

Age-related Wet Macular Degeneration Phase 1 Interventional 45 participants sought

CBCC Global Research Site:001 — Augusta, Georgia (9.2 mi) · Sponsor: Caregen Co. Ltd.

See eligibility & contact on ClinicalTrials.gov (NCT06132035)

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

Intracerebral Hemorrhage, Stroke N/A Observational 1,018 participants sought

Augusta University-Neuroscience Center — Augusta, Georgia (9.2 mi) · Sponsor: Zeenat Qureshi Stroke Institute

See eligibility & contact on ClinicalTrials.gov (NCT06402968)

Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)

Hepatitis Phase 3 Interventional 350 participants sought

Augusta University — Augusta, Georgia (9.2 mi) · Sponsor: Bausch Health Americas, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07428538)

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

Malignant Solid Neoplasm N/A Observational 2,062 participants sought

Augusta Oncology Associates PC-D'Antignac — Augusta, Georgia (9.2 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT04871542)

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

High Grade Epithelial Ovarian Cancer, High Grade Serous Ovarian Cancer Phase 1, Phase 2 Interventional 952 participants sought

Augusta University Georgia Cancer Center — Augusta, Georgia (9.2 mi) · Sponsor: Genmab

See eligibility & contact on ClinicalTrials.gov (NCT05579366)

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Parkinson Disease, Parkinson Phase 2 Interventional 150 participants sought

Augusta University — Augusta, Georgia (9.2 mi) · Sponsor: Neuron23 Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06680830)

DALY II USA/ MB-CART2019.1 for DLBCL

Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B Cell Lymphoma Phase 2 Interventional 315 participants sought

Georgia Cancer Center at Augusta University — Augusta, Georgia (9.2 mi) · Sponsor: Miltenyi Biomedicine GmbH

See eligibility & contact on ClinicalTrials.gov (NCT04792489)

Exactech Shoulder Post Market Clinical Follow-up Study

Osteo Arthritis Shoulders, Osteonecrosis N/A Observational 20,000 participants sought

Orthopedic and Sports Medicine — Augusta, Georgia (9.2 mi) · Sponsor: Exactech

See eligibility & contact on ClinicalTrials.gov (NCT05603728)

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

High Grade Osteosarcoma, Localized Osteosarcoma Phase 2, Phase 3 Interventional 1,122 participants sought

Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05691478)

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Ovarian Cancer, Fallopian Tube Cancer Phase 3 Interventional 770 participants sought

Augusta University - Georgia Cancer Center ( Site 0066) — Augusta, Georgia (9.2 mi) · Sponsor: Merck Sharp & Dohme LLC

See eligibility & contact on ClinicalTrials.gov (NCT06824467)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought

Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT07198074)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought

Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06337318)

CraniSeal Post Approval Study

Leak, Cerebrospinal Fluid Phase 4 Interventional 224 participants sought

Augusta University — Augusta, Georgia (9.2 mi) · Sponsor: Pramand LLC

See eligibility & contact on ClinicalTrials.gov (NCT06406790)

Actively enrolling

Studies you may be able to join near Augusta

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Google-rated

Top-rated research centers in Augusta

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Southeastern Clinical Research Institute

1521 Anthony Rd, Augusta, GA 30904

(706) 922-3005

Website

Masters of Clinical Research

1232 Augusta W Pkwy, Augusta, GA 30909

(706) 210-8890

Website

Telemedicine & Advanced Technology Research Center (TATRC) Digital Health Innovation Center (DHIC)

300 E Hospital Rd, Fort Gordon, GA 30905

(301) 619-7927

Website

Georgia Prevention Institute

★ 4.8

1499 Walton Wy, Augusta, GA 30912

(706) 721-4534

Website

"A place for and of exercise and health that lives up to the standard of pushing yourself. I am still sore."

— Richard Drake, 4★

Georgia Cancer Center - M. Bert Storey Research Building

★ 5.0

1410 Laney Walker Blvd, Augusta, GA 30912

(706) 721-0570

Website

"Such professional caring care throughout all stages of care - from physicians to auxiliary medical care to clinic and infusion nurses to medical assi…"

— Genie Fulcher, 5★

Clinical trials in Augusta: what's recruiting

The Augusta area currently has 184 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Augusta, the most active research areas are:

Cancer & Oncology13 studies
Liver & Kidney2 studies
Brain & Mental Health2 studies
Diabetes & Metabolism1 studies
Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Augusta, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Augusta

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Augusta participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How do I join a study in Augusta, GA?

Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.

Is compensation for clinical trials taxable?

In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.

What is the difference between a research center and a hospital study in Augusta?

Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

How often do new paid studies open in Augusta?

Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Augusta.

Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Augusta typically complete one or two studies per year.

Paid clinical trials near Augusta

Other metros within reach

Columbia, SC192 Athens, GA71 Mauldin, SC380 Greenville, SC382 Spartanburg, SC366 Savannah, GA171 Macon, GA75 Warner Robins, GA75

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Augusta Chronic Kidney Disease (HealthMatch) in Augusta Bladder Issues Due To Spinal Cord Injury in Augusta All conditions

More of GA

Atlanta1,713 Savannah171 Gainesville146 Macon75 Warner Robins75 Athens71 Columbus68

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts